Discovery, design and synthesis of Y-shaped peroxisome proliferator-activated receptor delta agonists as potent anti-obesity agents in vivo.
Article Details
- CitationCopy to clipboard
Ham J, Hwang H, Kim E, Kim JA, Cho SJ, Ko J, Lee W, Lee J, Holla H, Banerjee J, Kim S, Yang I, Lee HJ, Shin K, Choi H, Nam SJ, Tak J, Hahn D, Oh T, Won DH, Lee TG, Choi J, Park MS, Seok C, Chin J, Kang H
Discovery, design and synthesis of Y-shaped peroxisome proliferator-activated receptor delta agonists as potent anti-obesity agents in vivo.
Eur J Med Chem. 2012 Jul;53:190-202. doi: 10.1016/j.ejmech.2012.03.055. Epub 2012 Apr 6.
- PubMed ID
- 22534184 [ View in PubMed]
- Abstract
We have discovered and demonstrated the in vitro and in vivo PPARdelta-selective activity of novel Y-shaped agonists. These compounds activated hPPARdelta with EC(50) values between 1 and 523 nM. Surprisingly, compounds 10a, 11d, 11e and 11f were the most potent and most selective hPPARdelta agonists with 10(4)-fold selectivity over the other two subtypes, namely, hPPARalpha and hPPARgamma. The PPARdelta ligands 10a, 11e and 11f showed good bioavailability and in vivo efficacy.
DrugBank Data that Cites this Article
- Binding Properties
Drug Target Property Measurement pH Temperature (°C) Cardarine Peroxisome proliferator-activated receptor alpha EC 50 (nM) 229 N/A N/A Details Cardarine Peroxisome proliferator-activated receptor delta EC 50 (nM) 2.5 N/A N/A Details Cardarine Peroxisome proliferator-activated receptor delta EC 50 (nM) 24 N/A N/A Details